Trexquant Investment LP Nuvation Bio Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.24 - $5.85 $142,663 - $257,587	-44,032 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.6 - $8.83 $89,957 - $172,679	19,556 Added 79.9%	44,032 $232,000
Q4 2021 Feb 14, 2022	BUY	$7.75 - $10.05 $189,689 - $245,983	24,476 New	24,476 $208,000
Q3 2021 Nov 12, 2021	SELL	$7.78 - $10.0 $177,951 - $228,730	-22,873 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$9.22 - $14.48 $210,889 - $331,201	22,873 New	22,873 $213,000

152

123M

9.7K

6.5K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $480M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.